![Habib Dable](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
En la actualidad, Habib J. Dable es Presidente, Director General y Director de Acceleron Pharma, Inc. Anteriormente ocupó el cargo de Presidente de Productos Farmacéuticos de EE.UU. en Bayer AG y Vicepresidente Ejecutivo y Director Global de Medicina Especializada en Bayer HealthCare Pharmaceuticals, Inc. (una filial de Bayer AG). Obtuvo un MBA y una licenciatura en la Universidad de New Brunswick.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
TYRA BIOSCIENCE, INC -.--% | 16/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
PEPGEN INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 05/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PEPGEN INC. | Director/Miembro de la Junta | 22/09/2022 |
| RELAY THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/11/2025 |
| SPYGLASS PHARMA, INC. | Director/Miembro de la Junta | 05/02/2026 |
| TYRA BIOSCIENCES, INC. | Director/Miembro de la Junta | 16/04/2026 |
RA Ventures, Inc.
 RA Ventures, Inc. RA Ventures, Inc., operating as RA Capital Management, is a multi-stage investment and company-building firm focused on healthcare, life sciences, and climate and sustainability technologies. The private company is based in MN. The firm invests in and supports companies developing drugs, medical devices, diagnostics, research tools, and environmental solutions aimed at improving human and planetary health. RA Capital employs an evidence-based, data-driven investment approach supported by internal research teams, and offers strategic support including incubation, American company creation, financing, technology transfer, and executive recruitment. RA Capital also supports social responsibility initiatives such as affordable drug access and sustainable environmental solutions. The firm collaborates with academia and entrepreneurs to translate scientific discoveries into products, provides flexible models for founder involvement, and fosters community engagement and knowledge sharing through online platforms. | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director/Miembro de la Junta | 23/04/2026 |
| BLUEPRINT MEDICINES CORPORATION | Director/Miembro de la Junta | 17/07/2025 |
| JADE BIOSCIENCES, INC. | Presidente | 28/04/2025 |
| ALBIREO PHARMA, INC. | Director/Miembro de la Junta | 02/03/2023 |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of New Brunswick
 University of New Brunswick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
RA Ventures, Inc.
RA Ventures, Inc. RA Ventures, Inc., operating as RA Capital Management, is a multi-stage investment and company-building firm focused on healthcare, life sciences, and climate and sustainability technologies. The private company is based in MN. The firm invests in and supports companies developing drugs, medical devices, diagnostics, research tools, and environmental solutions aimed at improving human and planetary health. RA Capital employs an evidence-based, data-driven investment approach supported by internal research teams, and offers strategic support including incubation, American company creation, financing, technology transfer, and executive recruitment. RA Capital also supports social responsibility initiatives such as affordable drug access and sustainable environmental solutions. The firm collaborates with academia and entrepreneurs to translate scientific discoveries into products, provides flexible models for founder involvement, and fosters community engagement and knowledge sharing through online platforms. | |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
SpyGlass Pharma Inc
 SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
